Vanda Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Vanda Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 24% to $192,640,000. Profit margin reached 1%. Total operating expenses were $191,796,000.
Profit Margin
| 2014 | 50.15M | 20.18M | 40.25% |
|---|---|---|---|
| 2015 | 109.92M | -39.86M | -36.27% |
| 2016 | 146.01M | -18.01M | -12.33% |
| 2017 | 165.08M | -15.56M | -9.43% |
| 2018 | 193.11M | 25.20M | 13.05% |
| 2019 | 227.18M | 115.55M | 50.86% |
| 2020 | 248.16M | 23.33M | 9.4% |
| 2021 | 268.68M | 33.15M | 12.34% |
| 2022 | 254.38M | 6.27M | 2.47% |
| 2023 | 192.64M | 2.50M | 1.3% |
VNDA Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 192.64M | 254.38M | 268.68M | 248.16M | 227.18M | 193.11M | 165.08M | 146.01M | 109.92M | 50.15M |
Cost of revenue | 14.79M | 24.28M | 25.62M | 23.36M | 24.48M | 20.50M | 17.84M | 24.71M | 23.46M | 1.58M |
Gross profit | 177.84M | 230.1M | 243.05M | 224.80M | 202.7M | 172.61M | 147.23M | 121.30M | 86.46M | 48.57M |
Operating exp. | ||||||||||
Research and development | 76.82M | 85.77M | 75.36M | 55.57M | 48.64M | 43.59M | 38.54M | 29.15M | 29.14M | 19.23M |
Selling and marketing | 500K | 2.6M | 6.7M | 12.6M | 3.2M | 0 | 1.3M | 0 | 3.4M | 5M |
Total operating expenses | 191.79M | 223.77M | 200.88M | 197.56M | 179.89M | 150.87M | 164.13M | 139.87M | 126.64M | 106.12M |
Operating income | -13.95M | 6.32M | 42.16M | 27.23M | 22.81M | 21.73M | -16.90M | -18.57M | -40.18M | 20.06M |
Other income (expenses), net | 20.29M | 4.97M | 199K | 4.41M | 6.21M | 3.60M | 1.47M | 665K | 320K | 124K |
Income before tax | 6.33M | 11.3M | 42.36M | 31.65M | 29.02M | 25.34M | -15.43M | -17.90M | -39.86M | 20.18M |
Income tax expense | 3.83M | 5.02M | 9.21M | 8.31M | -86.52M | 138K | 136K | 104K | 0 | -77.61M |
Net income | 2.50M | 6.27M | 33.15M | 23.33M | 115.55M | 25.20M | -15.56M | -18.01M | -39.86M | 20.18M |
Earnings per share | ||||||||||
Basic EPS | 0.04 | 0.11 | 0.6 | 0.43 | 2.17 | 0.5 | -0.35 | -0.41 | -0.94 | 0.58 |
Diluted EPS | 0.04 | 0.11 | 0.58 | 0.42 | 2.11 | 0.48 | -0.35 | -0.41 | -0.94 | 0.55 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |